The largest database of trusted experimental protocols

Anti pchk1 ser345 133d3

Manufactured by Cell Signaling Technology
Sourced in United Kingdom

Anti-pCHK1 (Ser345) (133D3) is a monoclonal antibody that recognizes the phosphorylated form of CHK1 protein at serine 345. This antibody is designed for research use and can be used to detect and study the activated form of CHK1, a key regulator of the DNA damage response pathway.

Automatically generated - may contain errors

2 protocols using anti pchk1 ser345 133d3

1

Immunoblotting of Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed and protein extracts boiled and loaded on 10% or 15% polyacrylamide gels. After electrophoretic separation, the proteins were transferred to PVDF membranes, which were blocked with 5% milk powder in TBS + 0.1% Tween 20 (TBS-T) for 1 hour. Incubation of the primary antibody in TBS-T was performed at 4°C overnight. Membranes were then washed and stained with secondary antibody. Chemiluminescence was elicited using Western Lightning Ultra from PerkinElmer or Clarity Western ECL Substrate from Bio-Rad Laboratories (Munich, Germany), respectively, according to the manufacturers' instructions. The following primary antibodies were used: anti‐Caspase 3, anti‐cleaved Caspase 3 (Asp175), anti‐Caspase 8 (1C12), anti-PARP, anti-pCHK1 (Ser345) (133D3), and anti-PRIM1 (8G10) from Cell Signaling Technology (Cambridge, UK); anti-ATR (N-19), anti‐Caspase 9 (H-170), anti-Cdc25A (5H51), anti-CHK1 (G4), anti‐Cyclin A (H-432), and anti-Wee1 (B-11) from Santa Cruz Biotechnology (Dallas, TX); and anti‐β-Actin (AC-15) from Sigma-Aldrich. HRP-conjugated anti-goat, anti-rat, anti-mouse, and anti-rabbit antibodies from Santa Cruz Biotechnology were used as secondary antibodies.
+ Open protocol
+ Expand
2

Immunoblotting Procedure for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting was performed as described previously39 (link). In short, cells were lysed and protein extracts were boiled and loaded on 10% polyacrylamide gels. After electrophoretic separation, the proteins were transferred to PVDF membranes, which were blocked with 5% milk powder in Tris-buffered saline + 0.1% Tween 20 (TBS-T) for 1 h. Incubation of primary antibody in TBS-T was performed at 4 °C overnight. Membranes were then washed and stained with secondary antibody. Chemiluminescence was elicited using Western Lightning Ultra from PerkinElmer (Waltham, MA, USA) or Clarity Western ECL Substrate from Bio-Rad Laboratories (Hercules, CA, USA), respectively, according to the manufacturers’ instructions. The following primary antibodies were used: anti-caspase 3, anti-cleaved caspase 3 (Asp175), anti-PARP, and anti-pCHK1(Ser345) (133D3) from Cell Signaling (Cambridge, UK), anti-CHK1 (G-4) and anti-POLD1 (A9) from Santa Cruz Biotechnology (Dallas, TX, USA), and peroxidase-conjugated anti-β-Actin (AC-15) from Sigma-Aldrich (Hamburg, Germany). HRP-conjugated anti-rabbit, anti-goat and anti-mouse antibodies from Santa Cruz Biotechnology were used as secondary antibodies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!